Curicef-TZ 1.125gm Injection
Marketer
Curelab Healthcare
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Curicef-TZ 1.125gm Injection
Ceftazidime/Tazobactam 1.125g injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits bacterial proliferation, thus controlling infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation can compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (skin rashes, pruritus, edema, respiratory distress) require prompt emergency care. Inform your doctor about all current medications before commencing treatment. Expectant and nursing mothers should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration are recommended for optimal recovery. Your physician might order lab tests to monitor the medication's effects.
Primary Ingredients of Curicef-TZ 1.125gm Injection
No text provided to rephrase.
Uses of Curicef-TZ 1.125gm Injection
Infections caused by bacteria
Major Benefits of Curicef-TZ 1.125gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Curicef-TZ 1.125gm Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Curicef-TZ 1.125gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Curicef-TZ 1.125gm Injection works:
Ceftriaxone and Tazobactum, combined as Curicef-TZ 1.125gm Injection, offer a powerful antibacterial approach. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, complements this action by overcoming bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Curicef-TZ 1.125gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Curicef-TZ (1.125 gm) is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Curicef-TZ 1.125gm Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the course of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Curicef-TZ 1.125gm Injection might induce drowsiness, blurred vision, or dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Curicef-TZ 1.125gm Injection use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Administering Curicef-TZ 1.125gm Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Curicef-TZ 1.125gm Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Curicef-TZ 1.125gm Injection :
Omit a Curicef-TZ 1.125gm Injection dose? Seek your physician's advice.
Facts to Know About Curicef-TZ 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently